Kirin is a diversified global group that blends beverages, health science, and biotechnology to offer consumer drinks and health therapeutics. Its fermentation expertise supports functional ingredients like LC-Plasma and Kyowa Kirin develops cancer and rare-disease therapies, leveraging a large global manufacturing and distribution network. The company differentiates itself by combining a biotech drug platform with consumer products and strong ESG practices, including 100% recycled PET packaging and a net-zero footprint, funded by the Kirin Health Innovation Fund. Its goal is to create long-term value by harmonizing nature, science, and industry to improve health and sustainability.
Company Size
201-500
Company Stage
IPO
Headquarters
Tokyo, Japan
Founded
1907
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?